peripher
blood
sampl
obtain
sar
patient
admit
new
territori
east
cluster
hospit
author
hospit
hong
kong
sampl
recruit
march
may
first
part
studi
blood
sampl
collect
sar
patient
day
hospit
admiss
well
day
fever
onset
inform
consent
obtain
patient
ethic
approv
obtain
institut
review
board
second
part
studi
blood
sampl
obtain
sar
patient
day
hospit
admiss
studi
patient
subsequ
serolog
evid
antibodi
sarscov
prognost
part
studi
previous
mention
sar
patient
subdivid
two
patient
group
patient
requir
admiss
intens
care
unit
icu
b
patient
requir
icu
admiss
nonicu
durat
hospit
blood
sampl
collect
edtacontain
plain
tube
plain
bottl
allow
stand
room
temperatur
h
complet
clot
blood
blood
sampl
centrifug
min
plasma
serum
care
transfer
plain
polypropylen
tube
plasma
sampl
recentrifug
min
supernat
collect
fresh
polypropylen
tube
viral
rna
extract
ml
plasmaserum
use
qiaamp
viral
rna
mini
reagent
set
qiagen
accord
manufactur
recommend
rna
elut
ave
buffer
includ
reagent
set
store
onestep
realtim
quantit
rtpcr
use
sarscov
rna
quantif
use
publicli
releas
full
genom
sequenc
sarscov
http
wwwncbinlmnihgov
design
two
rtpcr
system
specif
target
sarscov
genom
sequenc
primer
probe
show
perfect
align
publicli
avail
complet
genom
sequenc
sarscov
genbank
juli
access
no
system
target
polymeras
gene
polyprotein
nucleotid
access
sarsn
system
target
nucleocapsid
gene
n
nucleotid
access
sarscov
genom
primer
sequenc
forward
revers
duallabel
fluoresc
probe
fam
atggtcatgtgtggcggctcacta
tamra
fam
tamra
sarsn
primer
sequenc
forward
revers
duallabel
fluoresc
probe
fam
tgctagacagattgaaccagcttg
tamra
calibr
curv
sarscov
rna
quantif
prepar
serial
dilut
hplcpurifi
singlestrand
synthet
dna
oligonucleotid
proligo
concentr
rang
copi
initi
concentr
synthet
oligonucleotid
determin
measur
absorb
nm
assay
abl
detect
copi
calibr
target
reaction
mixtur
indic
fig
data
supplement
accompani
onlin
version
articl
athttp
concentr
sarscov
express
copiesml
plasmaserum
recoveri
experi
done
report
concentr
copiesml
minimum
estim
sequenc
synthet
dna
oligonucleotid
sarsn
calibr
respect
rtpcr
reaction
set
accord
manufactur
instruct
ez
rtth
rna
pcr
reagent
set
appli
biosystem
reaction
volum
primer
fluoresc
probe
use
concentr
nm
respect
extract
plasmaserum
rna
use
amplif
thermal
profil
use
analysi
follow
reaction
initi
min
includ
uracil
nglycosylas
act
follow
revers
transcript
min
denatur
cycl
pcr
carri
denatur
annealingextens
min
sampl
analyz
duplic
calibr
curv
run
parallel
analysi
multipl
neg
water
blank
also
includ
everi
analysi
statist
analysi
perform
sigmastat
softwar
spss
student
ttest
use
comparison
age
icu
nonicu
group
test
use
comparison
serum
sarscov
rna
concentr
icu
nonicu
group
pearson
correl
analysi
use
assess
correl
sarscov
rna
concentr
sarsn
rtpcr
system
determin
quantit
perform
sarscov
rtpcr
assay
use
assay
amplifi
serial
dilut
calibr
synthet
dna
oligonucleotid
base
sarscov
genom
sequenc
calibr
curv
polymeras
sarsn
nucleocapsid
amplif
system
demonstr
dynam
rang
copi
copi
semilogarithm
plot
differ
calibr
concentr
threshold
cycl
yield
correl
coeffici
system
sarsn
system
amplif
step
assay
suffici
allow
detect
copi
target
reaction
mixtur
correspond
detect
limit
copiesml
plasmaserum
assay
consist
demonstr
low
detect
limit
indic
amplif
calibr
separ
analys
abl
detect
copi
synthet
oligonucleotid
reaction
mixtur
indic
fig
onlin
data
supplement
determin
precis
whole
analyt
procedur
includ
rna
extract
revers
transcript
amplif
perform
replic
rna
extract
sampl
pool
plasma
obtain
sar
patient
subject
extract
rna
sampl
rtpcr
assay
cv
copi
number
replic
analys
sarsn
amplif
system
copiesml
copiesml
respect
carri
recoveri
experi
actual
viru
concentr
test
sampl
would
expect
higher
actual
concentr
measur
realtim
rtpcr
howev
would
affect
interpret
data
reproduc
rna
extract
quantit
rtpcr
step
test
detail
system
would
serv
reproduc
valid
comparison
viru
concentr
within
patient
differ
time
differ
patient
investig
whether
sarscov
rna
could
detect
plasma
evalu
rel
use
plasma
sarscov
measur
differ
stage
diseas
studi
serolog
confirm
sar
patient
plasma
sampl
taken
admiss
repres
mean
day
fever
onset
rang
day
addit
sampl
taken
patient
day
fever
onset
realtim
rtpcr
system
detect
plasma
sarscov
rna
detect
limit
determin
serial
dilut
calibr
six
patient
admiss
detect
rate
remain
day
fell
day
fever
onset
tabl
neg
control
sarscov
rna
detect
plasma
sampl
obtain
healthi
individu
test
detect
sarscov
rna
serum
instead
plasma
earli
stage
sar
analyz
serum
sampl
obtain
sar
patient
day
hospit
admiss
use
realtim
rtpcr
system
patient
serum
sampl
taken
mean
day
rang
day
onset
fever
one
patient
fever
ill
system
abl
detect
sarscov
rna
sampl
includ
patient
fever
detect
rate
essenti
confirm
plasmabas
result
first
cohort
describ
median
serum
sarscov
rna
concentr
copiesml
neg
control
sarscov
rna
detect
serum
sampl
obtain
healthi
individu
confirm
data
gener
rtpcr
system
use
anoth
realtim
rtpcr
system
sarsn
target
nucleocapsid
gene
sarscov
genom
repeat
serum
analysi
sarsn
system
abl
detect
sarscov
rna
sampl
median
serum
sarscov
rna
concentr
copiesml
correl
coeffici
sarscov
rna
concentr
sarsn
rtpcr
system
pearson
correl
analysi
p
fig
neg
control
sarscov
rna
detect
sarsn
rtpcr
system
serum
sampl
obtain
healthi
individu
determin
potenti
prognost
implic
admiss
serum
sarscov
concentr
previous
mention
group
patient
stratifi
requir
admiss
icu
n
n
durat
hospit
mean
age
two
group
patient
year
respect
student
ttest
p
maletofemal
ratio
icu
group
nonicu
group
rtpcr
assay
median
serum
sarscov
concentr
icu
nonicu
group
copiesml
respect
see
fig
onlin
data
supplement
differ
serum
sarscov
concentr
group
statist
signific
test
p
sarsn
rtpcr
assay
median
serum
sarscov
concentr
icu
nonicu
group
copiesml
respect
see
fig
onlin
data
supplement
differ
serum
sarscov
concentr
group
also
statist
signific
test
p
report
demonstr
sarscov
rna
detect
plasma
serum
patient
earli
stage
sar
detect
rate
system
sarsn
system
find
demonstr
plasmaserum
sarscov
measur
sensit
method
detect
sarscov
infect
first
week
fever
onset
sensit
especi
serum
much
higher
sensit
report
clinic
specimen
type
similar
stage
infect
exampl
rtpcr
analysi
nasopharyng
aspir
report
sensit
first
week
symptom
onset
data
present
also
demonstr
median
concentr
serum
sarscov
rna
patient
requir
icu
admiss
cours
hospit
higher
median
concentr
requir
intens
care
measur
sarsn
rtpcr
system
respect
result
show
strong
correl
serum
sarscov
rna
concentr
obtain
obtain
sarsn
rtpcr
system
although
median
serum
sarscov
concentr
differ
differ
observ
quantit
valu
may
result
coexist
subgenom
fragment
n
gene
full
viru
genom
serum
could
subject
investig
envis
plasmaserum
sarscov
measur
function
synergist
manner
exist
diagnost
strategi
sar
thu
plasmaserum
rtpcr
perform
high
sensit
first
week
diseas
rtpcr
analysi
stool
respiratori
sampl
perform
second
week
serolog
test
antibodi
sarscov
use
day
onward
avail
diagnost
test
earli
identif
sar
patient
could
potenti
use
public
health
control
sar
furthermor
data
show
serum
sarscov
measur
prognost
marker
use
even
first
day
hospit
admiss
apart
obviou
clinic
signific
observ
also
suggest
high
system
viral
load
may
lead
sever
tissu
damag
either
directli
indirectli
activ
potenti
damag
immun
reaction
elucid
latter
possibl
would
fertil
ground
futur
research
